MannKind Corporation is a biopharmaceutical company focused on cardiometabolic and orphan lung diseases. Its commercial products include Afrezza (inhaled insulin), Furoscix (subcutaneous furosemide), and V-Go (wearable insulin delivery device). It also supplies Tyvaso DPI (inhaled treprostinil) manufactured for partner United Therapeutics. Pipeline programs include MNKD-201 (inhaled nintedanib for IPF) and MNKD-701 (inhaled bumetanide), leveraging its proprietary Technosphere dry-powder inhaler platform.
expected 2026-11-20
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-073516 | EDGAR | 98K words |
| 2025-02-26 | 2024-12-31 | 0000950170-25-027735 | EDGAR | 87K words |
| 2024-02-27 | 2023-12-31 | 0000950170-24-021423 | EDGAR | 87K words |
| 2023-02-23 | 2022-12-31 | 0001564590-23-002309 | EDGAR | — |
| 2022-02-24 | 2021-12-31 | 0001564590-22-006702 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0001564590-21-008440 | EDGAR | — |
| 2020-02-25 | 2019-12-31 | 0001564590-20-006198 | EDGAR | — |
| 2019-02-26 | 2018-12-31 | 0001564590-19-004263 | EDGAR | — |
| 2018-02-27 | 2017-12-31 | 0001564590-18-003510 | EDGAR | — |
| 2017-03-16 | 2016-12-31 | 0001193125-17-085519 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001193125-26-335054 | EDGAR | 65K words |
| 2025-11-05 | 2025-09-30 | 0001193125-25-265813 | EDGAR | 68K words |
| 2025-08-06 | 2025-06-30 | 0000950170-25-103535 | EDGAR | 64K words |
| 2025-05-08 | 2025-03-31 | 0000950170-25-066429 | EDGAR | 57K words |
| 2024-11-07 | 2024-09-30 | 0000950170-24-123296 | EDGAR | 64K words |
| 2024-08-07 | 2024-06-30 | 0000950170-24-092288 | EDGAR | 63K words |
| 2024-05-08 | 2024-03-31 | 0000950170-24-055661 | EDGAR | 58K words |
| 2023-11-07 | 2023-09-30 | 0000950170-23-060253 | EDGAR | 62K words |
| 2023-08-07 | 2023-06-30 | 0000950170-23-039074 | EDGAR | 61K words |
| 2023-05-09 | 2023-03-31 | 0000950170-23-019668 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001564590-22-036933 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001564590-22-028753 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-21 | 0001193125-26-361105 | EDGAR | 1K words |
| 2026-08-05 | 0001193125-26-335016 | EDGAR | 5K words |
| 2026-07-24 | 0001193125-26-316041 | EDGAR | 1K words |
| 2026-02-26 | 0001193125-26-073509 | EDGAR | 5K words |
| 2025-11-10 | 0001193125-25-273321 | EDGAR | 1K words |
| 2025-11-05 | 0001193125-25-265810 | EDGAR | 5K words |
| 2025-10-09 | 0001193125-25-236064 | EDGAR | 13K words |
| 2025-08-27 | 0000950170-25-111586 | EDGAR | 2K words |
| 2025-08-25 | 0001193125-25-186994 | EDGAR | 3K words |
| 2025-08-06 | 0000950170-25-103532 | EDGAR | 5K words |
286 total filings indexed. 254 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000899460 |
| Ticker | MNKD |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | Danbury, Connecticut |
| Website | https://www.mannkindcorp.com |
| Listed | 2004-07-28 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/MNKD (~200 tokens, structured JSON with cryptographic provenance)